{"id":"https://openalex.org/W3045691885","doi":"https://doi.org/10.1101/2020.07.28.20160630","title":"Nicotine-replacement therapy, as a surrogate of smoking, and the risk of hospitalization with Covid-19 and all-cause mortality: a nationwide, observational cohort study in France","display_name":"Nicotine-replacement therapy, as a surrogate of smoking, and the risk of hospitalization with Covid-19 and all-cause mortality: a nationwide, observational cohort study in France","publication_year":2020,"publication_date":"2020-07-30","ids":{"openalex":"https://openalex.org/W3045691885","doi":"https://doi.org/10.1101/2020.07.28.20160630","mag":"3045691885"},"language":"en","primary_location":{"id":"doi:10.1101/2020.07.28.20160630","doi":"https://doi.org/10.1101/2020.07.28.20160630","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2020.07.28.20160630","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2020/07/30/2020.07.28.20160630.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.medrxiv.org/content/medrxiv/early/2020/07/30/2020.07.28.20160630.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059005646","display_name":"Mahmoud Zureik","orcid":"https://orcid.org/0000-0002-8393-4217","observed_orcids":["https://orcid.org/0000-0002-8393-4217"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I195731000","display_name":"Universit\u00e9 de Versailles Saint-Quentin-en-Yvelines","ror":"https://ror.org/03mkjjy25","country_code":"FR","type":"education","lineage":["https://openalex.org/I195731000","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I4210103698","display_name":"Centre de recherche en Epid\u00e9miologie et Sant\u00e9 des Populations","ror":"https://ror.org/01ed4t417","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I195731000","https://openalex.org/I277688954","https://openalex.org/I4210097159","https://openalex.org/I4210103698","https://openalex.org/I4210164847","https://openalex.org/I4405259118"]},{"id":"https://openalex.org/I4210120216","display_name":"Epi-Phare","ror":"https://ror.org/02nt00p03","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210120216"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Mahmoud Zureik","raw_affiliation_strings":["EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance","University Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Anti-infective evasion and pharmacoepidemiology, CESP, 78180, Montigny le Bretonneux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance","institution_ids":["https://openalex.org/I4210120216"]},{"raw_affiliation_string":"University Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Anti-infective evasion and pharmacoepidemiology, CESP, 78180, Montigny le Bretonneux, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I195731000","https://openalex.org/I277688954","https://openalex.org/I4210103698"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030789551","display_name":"B\u00e9rang\u00e8re Baricault","orcid":"https://orcid.org/0000-0001-5835-7668","observed_orcids":["https://orcid.org/0000-0001-5835-7668"]},"institutions":[{"id":"https://openalex.org/I4210120216","display_name":"Epi-Phare","ror":"https://ror.org/02nt00p03","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210120216"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B\u00e9rang\u00e8re Baricault","raw_affiliation_strings":["EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance","institution_ids":["https://openalex.org/I4210120216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034818701","display_name":"Cl\u00e9mentine Vabre","orcid":"https://orcid.org/0000-0003-0132-961X","observed_orcids":["https://orcid.org/0000-0003-0132-961X"]},"institutions":[{"id":"https://openalex.org/I4210120216","display_name":"Epi-Phare","ror":"https://ror.org/02nt00p03","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210120216"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Cl\u00e9mentine Vabre","raw_affiliation_strings":["EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance","institution_ids":["https://openalex.org/I4210120216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057751193","display_name":"Laura Semenzato","orcid":"https://orcid.org/0000-0002-8305-3487","observed_orcids":["https://orcid.org/0000-0002-8305-3487"]},"institutions":[{"id":"https://openalex.org/I4210120216","display_name":"Epi-Phare","ror":"https://ror.org/02nt00p03","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210120216"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laura Semenzato","raw_affiliation_strings":["EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance","institution_ids":["https://openalex.org/I4210120216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014454712","display_name":"J\u00e9r\u00f4me Drouin","orcid":"https://orcid.org/0000-0003-2017-7041","observed_orcids":["https://orcid.org/0000-0003-2017-7041"]},"institutions":[{"id":"https://openalex.org/I4210120216","display_name":"Epi-Phare","ror":"https://ror.org/02nt00p03","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210120216"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J\u00e9r\u00f4me Drouin","raw_affiliation_strings":["EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance","institution_ids":["https://openalex.org/I4210120216"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Fran\u00e7ois Cuenot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120216","display_name":"Epi-Phare","ror":"https://ror.org/02nt00p03","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210120216"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fran\u00e7ois Cuenot","raw_affiliation_strings":["EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance","institution_ids":["https://openalex.org/I4210120216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079683534","display_name":"La\u00ebtitia Penso","orcid":"https://orcid.org/0000-0003-1562-0168","observed_orcids":["https://orcid.org/0000-0003-1562-0168"]},"institutions":[{"id":"https://openalex.org/I4210120216","display_name":"Epi-Phare","ror":"https://ror.org/02nt00p03","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210120216"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laetitia Penso","raw_affiliation_strings":["EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance","institution_ids":["https://openalex.org/I4210120216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064970024","display_name":"Philippe Herlemont","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120216","display_name":"Epi-Phare","ror":"https://ror.org/02nt00p03","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210120216"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe Herlemont","raw_affiliation_strings":["EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance","institution_ids":["https://openalex.org/I4210120216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057668291","display_name":"\u00c9. Sbidian","orcid":"https://orcid.org/0000-0002-1267-5270","observed_orcids":["https://orcid.org/0000-0002-1267-5270"]},"institutions":[{"id":"https://openalex.org/I197681013","display_name":"Universit\u00e9 Paris-Est Cr\u00e9teil","ror":"https://ror.org/05ggc9x40","country_code":"FR","type":"education","lineage":["https://openalex.org/I197681013","https://openalex.org/I2800365227"]},{"id":"https://openalex.org/I4210120216","display_name":"Epi-Phare","ror":"https://ror.org/02nt00p03","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210120216"]},{"id":"https://openalex.org/I4394709234","display_name":"Epidemiology in dermatology and evaluation of therapeutics","ror":"https://ror.org/011gnc761","country_code":"FR","type":"facility","lineage":["https://openalex.org/I197681013","https://openalex.org/I2800365227","https://openalex.org/I4394709234"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Emilie Sbidian","raw_affiliation_strings":["EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance","University Paris-Est Cr\u00e9teil, Research Unit Epidemiology in dermatology and evaluation of therapeutics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance","institution_ids":["https://openalex.org/I4210120216"]},{"raw_affiliation_string":"University Paris-Est Cr\u00e9teil, Research Unit Epidemiology in dermatology and evaluation of therapeutics","institution_ids":["https://openalex.org/I197681013","https://openalex.org/I4394709234"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080099253","display_name":"Alain Weill","orcid":"https://orcid.org/0000-0001-8687-9092","observed_orcids":["https://orcid.org/0000-0001-8687-9092"]},"institutions":[{"id":"https://openalex.org/I4210120216","display_name":"Epi-Phare","ror":"https://ror.org/02nt00p03","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210120216"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Alain Weill","raw_affiliation_strings":["EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance","institution_ids":["https://openalex.org/I4210120216"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078220154","display_name":"Mathi\u00e9u Molimard","orcid":"https://orcid.org/0000-0002-4346-8346","observed_orcids":["https://orcid.org/0000-0002-4346-8346"]},"institutions":[{"id":"https://openalex.org/I15057530","display_name":"Universit\u00e9 de Bordeaux","ror":"https://ror.org/057qpr032","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210106115","display_name":"Bordeaux Population Health","ror":"https://ror.org/00xzzba89","country_code":"FR","type":"facility","lineage":["https://openalex.org/I15057530","https://openalex.org/I154526488","https://openalex.org/I4210106115"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Mathieu Molimard","raw_affiliation_strings":["Service of medical pharmacology, university of Bordeaux, Inserm, UMR 1219, Bordeaux population health research center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service of medical pharmacology, university of Bordeaux, Inserm, UMR 1219, Bordeaux population health research center","institution_ids":["https://openalex.org/I15057530","https://openalex.org/I154526488","https://openalex.org/I4210106115"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046017646","display_name":"Rosemary Dray\u2010Spira","orcid":"https://orcid.org/0000-0001-7646-3667","observed_orcids":["https://orcid.org/0000-0001-7646-3667"]},"institutions":[{"id":"https://openalex.org/I4210120216","display_name":"Epi-Phare","ror":"https://ror.org/02nt00p03","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210120216"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Rosermary Dray-Spira","raw_affiliation_strings":["EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance","institution_ids":["https://openalex.org/I4210120216"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079651779","display_name":"J\u00e9r\u00e9mie Botton","orcid":"https://orcid.org/0000-0002-4814-6370","observed_orcids":["https://orcid.org/0000-0002-4814-6370"]},"institutions":[{"id":"https://openalex.org/I4210120216","display_name":"Epi-Phare","ror":"https://ror.org/02nt00p03","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210120216"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J\u00e9r\u00e9mie Botton","raw_affiliation_strings":["EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance","institution_ids":["https://openalex.org/I4210120216"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5059005646"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I195731000","https://openalex.org/I277688954","https://openalex.org/I4210103698","https://openalex.org/I4210120216"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10060","display_name":"Smoking Behavior and Cessation","score":0.7465999722480774,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10060","display_name":"Smoking Behavior and Cessation","score":0.7465999722480774,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.22269999980926514,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nicotine-replacement-therapy","display_name":"nicotine replacement therapy","score":0.9900000095367432},{"id":"https://openalex.org/keywords/smoking","display_name":"smoking","score":0.6510000228881836},{"id":"https://openalex.org/keywords/covid-19-hospitalization","display_name":"COVID-19 hospitalization","score":0.9269999861717224},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.9760000109672546},{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9129999876022339},{"id":"https://openalex.org/keywords/smoking-related-diseases","display_name":"smoking-related diseases","score":0.7549999952316284},{"id":"https://openalex.org/keywords/cancer","display_name":"cancer","score":0.32100000977516174},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.9210000038146973},{"id":"https://openalex.org/keywords/respiratory-diseases","display_name":"respiratory diseases","score":0.9789999723434448},{"id":"https://openalex.org/keywords/intubation","display_name":"intubation","score":0.5170000195503235}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8623345494270325},{"id":"https://openalex.org/C2780478649","wikidata":"https://www.wikidata.org/wiki/Q1189783","display_name":"Nicotine replacement therapy","level":3,"score":0.7554254531860352},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5316774249076843},{"id":"https://openalex.org/C2776269092","wikidata":"https://www.wikidata.org/wiki/Q1611074","display_name":"Residence","level":2,"score":0.5047131776809692},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5037021040916443},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.48431530594825745},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.47964102029800415},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4370054006576538},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.39282602071762085},{"id":"https://openalex.org/C2779547902","wikidata":"https://www.wikidata.org/wiki/Q28086552","display_name":"Nicotine","level":2,"score":0.38711342215538025},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2519076466560364},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.2296789288520813},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1101/2020.07.28.20160630","doi":"https://doi.org/10.1101/2020.07.28.20160630","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2020.07.28.20160630","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2020/07/30/2020.07.28.20160630.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1101/2020.07.28.20160630","doi":"https://doi.org/10.1101/2020.07.28.20160630","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2020.07.28.20160630","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2020/07/30/2020.07.28.20160630.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3045691885.pdf","grobid_xml":"https://content.openalex.org/works/W3045691885.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W1841586440","https://openalex.org/W2016722530","https://openalex.org/W2038687954","https://openalex.org/W2078740198","https://openalex.org/W2102255195","https://openalex.org/W2107031757","https://openalex.org/W2123251249","https://openalex.org/W2134319336","https://openalex.org/W2141778334","https://openalex.org/W2167489015","https://openalex.org/W2296520514","https://openalex.org/W2378098209","https://openalex.org/W2532057098","https://openalex.org/W2621586846","https://openalex.org/W2735301415","https://openalex.org/W2751852092","https://openalex.org/W2767910653","https://openalex.org/W2786599866","https://openalex.org/W2797152839","https://openalex.org/W2904014975","https://openalex.org/W2964473028","https://openalex.org/W3009314935","https://openalex.org/W3009885589","https://openalex.org/W3011260630","https://openalex.org/W3016395780","https://openalex.org/W3017932153","https://openalex.org/W3018448193","https://openalex.org/W3020220390","https://openalex.org/W3021543288","https://openalex.org/W3021685303","https://openalex.org/W3022206014","https://openalex.org/W3023082818","https://openalex.org/W3023346879","https://openalex.org/W3024193040","https://openalex.org/W3035256826","https://openalex.org/W3037156091","https://openalex.org/W3047144258","https://openalex.org/W4239321522","https://openalex.org/W6779640091"],"related_works":["https://openalex.org/W4229665579","https://openalex.org/W3021685303","https://openalex.org/W4294904978","https://openalex.org/W4401729414","https://openalex.org/W3112088381","https://openalex.org/W7155225737","https://openalex.org/W3217350186","https://openalex.org/W4206029644","https://openalex.org/W3087459619","https://openalex.org/W4409882542"],"abstract_inverted_index":{"Abstract":[0],"Introduction":[1],"Several":[2],"studies":[3,20,559],"have":[4],"reported":[5],"an":[6,198,370,467,524],"unexpectedly":[7],"low":[8],"prevalence":[9],"of":[10,27,40,46,57,170,174,321,347,373,435,464,527,534,547,567,577,583],"current":[11],"smoking":[12,28,570,584],"among":[13],"hospitalized":[14,201,352,470],"patients":[15,202,293,295,303,440,448],"with":[16,32,48,193,203,219,231,257,288,317,323,326,343,354,369,394,404,433,437,462,472,523,543],"Covid-19.":[17],"However,":[18],"these":[19,114,578],"mostly":[21],"compared":[22,209,325],"observed":[23],"to":[24,96,157,216,236,252,283,335,366,386,399,459,484,505,518,562],"expected":[25],"rates":[26],"without":[29,99,247,261,552],"direct":[30],"comparison":[31],"individual":[33],"controls.":[34],"Objective":[35],"To":[36],"examine":[37],"the":[38,54,74,82,91,109,151,164,237,242,297,305,309,389,423,442,450,491,531,564,575,580],"association":[39],"nicotine-replacement":[41,97,133,217,253,298,313,400,427,443,492,519],"therapy,":[42,520],"as":[43],"a":[44,65,191,195,227,318,344,544,591],"surrogate":[45],"smoking,":[47,514],"hospitalization":[49,192,287,322,436],"and":[50,108,123,139,180,205,275,301,418,446,557],"all-cause":[51,206,374],"mortality":[52,375,487,529],"during":[53,530],"first":[55,92,243,532],"wave":[56,533],"SARS-CoV-2":[58,535],"epidemic":[59,536,593],"in":[60,93,111,177,200,211,221,291,296,304,351,441,449,469,490,537,550,571],"France.":[61],"Methods":[62],"We":[63,86,116,208],"conducted":[64,87],"nationwide":[66],"matched":[67,162,256,403],"\u201cexposed/unexposed\u201d":[68],"cohort":[69],"study":[70,511],"using":[71,226],"information":[72],"from":[73,150],"French":[75,84,154],"national":[76],"health":[77,183,588],"data":[78],"system":[79],"which":[80],"covers":[81],"entire":[83,152],"population.":[85],"two":[88,158],"separate":[89],"analyses,":[90],"individuals":[94,160,212,222,246,260,328,353,393,471,551],"exposed":[95,145,215,251,398],"therapy":[98,134,218,254,299,314,338,401,428,444,493],"major":[100,248,262,395,553],"smoking-related":[101,249,263,396],"diseases":[102,250,397],"(cancer,":[103],"cardiovascular":[104],"and/or":[105,569],"respiratory":[106],"diseases)":[107],"second":[110,390],"those":[112,220],"presenting":[113],"conditions.":[115],"included":[117],"all":[118],"individuals,":[119],"aged":[120,267,410],"between":[121,135],"18":[122],"75":[124],"years,":[125],"who":[126,213,223],"had":[127],"been":[128],"reimbursed":[129],"at":[130],"least":[131],"one":[132],"November":[136],"15,":[137,141,281],"2019,":[138],"February":[140,280],"2020.":[142],"For":[143],"each":[144],"individual,":[146],"we":[147],"randomly":[148],"selected,":[149],"Metropolitan":[153,178],"population,":[155],"up":[156],"non-exposed":[159],"(1:2)":[161],"for":[163,587],"following":[165],"variables:":[166],"age":[167],"(same":[168],"year":[169],"birth),":[171],"sex,":[172],"department":[173],"residence":[175],"(n=96":[176],"France),":[179],"complementary":[181],"universal":[182],"insurance":[184],"(CMU-C).":[185],"The":[186],"three":[187],"end":[188],"points":[189],"were":[190,214,224,255,266,277,402,409,420],"Covid-19,":[194,204],"death":[196,350,465],"or":[197,349,466],"intubation":[199,348,468],"mortality.":[207],"outcomes":[210],"not,":[225],"multivariable":[228,311,425],"Cox":[229],"model":[230],"inverse":[232],"probability":[233],"weighting":[234],"according":[235],"propensity":[238],"score.":[239],"Results":[240],"In":[241,308,388,422],"analysis,":[244,312,391,426],"297,070":[245],"558,228":[258],"unexposed":[259,306,327,406,451],"diseases.":[264,555],"Individuals":[265,408],"on":[268,411],"average":[269,412],"45.6":[270],"years":[271,414],"(standard":[272,415],"deviation:":[273,416],"12.7)":[274],"48.8%":[276],"male.":[278,421],"From":[279],"2020":[282],"June":[284],"7,":[285],"2020,":[286],"Covid-19":[289,324,355,438,473,549,572],"occurred":[290],"647":[292],"(151":[294],"group":[300,445,494],"496":[302],"group).":[307],"main":[310,424],"was":[315,340,430,488,521,541],"associated":[316,342,432,522,542],"decreased":[319,345],"risk":[320,346,372,434,463,526,546],"(hazard":[329],"ratio,":[330,361,381,454,479,500],"0.50;":[331],"95%":[332,363,383,456,481,502],"CI,":[333,364,384,457,482,503],"0.41":[334],"0.61).":[336],"Nicotine-replacement":[337],"exposure":[339,429,517],"also":[341],"(13":[356],"vs.":[357,377,475,496],"73":[358],"patients,":[359,477],"hazard":[360,380,453,478,499],"0.31;":[362],"0.17":[365],"0.57)":[367],"but":[368],"increased":[371,525],"(251":[376],"231":[378],"deaths,":[379,498],"1.49;":[382],"1.24":[385],"1.80).":[387],"128,768":[392],"243,793":[405],"individuals.":[407],"55.3":[413],"11.4)":[417],"53.3%":[419],"neither":[431],"(240":[439],"398":[447],"group,":[452],"1.13;":[455],"0.94":[458],"1.38)":[460],"nor":[461],"(48":[474],"61":[476],"1.00;":[480],"0.65":[483],"1.54).":[485],"All-cause":[486],"higher":[489],"(1040":[495],"366":[497],"3.83;":[501],"3.41":[504],"4.31).":[506],"Conclusions":[507],"This":[508],"large-scale":[509],"observational":[510],"suggests":[512],"that":[513],"measured":[515],"by":[516],"overall":[528],"France,":[538],"although":[539],"it":[540],"lower":[545],"severe":[548],"related-smoking":[554],"Experimental":[556],"clinical":[558],"are":[560],"needed":[561],"disentangle":[563],"potential":[565],"mechanisms":[566],"nicotine":[568],"risk.":[573],"Whatever":[574],"nature":[576],"associations,":[579],"global":[581],"impact":[582],"is":[585],"harmful":[586],"even":[589],"over":[590],"short":[592],"period.":[594]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3}],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2020-08-03T00:00:00"}